Bank Pictet & Cie (Europe)’s Alexion Pharmaceuticals ALXN Stock Holding History

Bank Pictet & Cie (Europe)’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-34,060	Closed	-$3.9M	–	182
2020 Q3	$3.9M	Buy	+34,060	New	+$3.67M	0.22%	58
2019 Q2	–	Sell	-1,705	Closed	-$230K	–	175
2019 Q1	$230K	Buy	+1,705	New	+$212K	0.04%	142
2018 Q4	–	Sell	-2,195	Closed	-$305K	–	161
2018 Q3	$305K	Buy	2,195 +300	+16%	+$37.6K	0.04%	143
2018 Q2	$235K	Sell	1,895 -4,200	-69%	-$491K	0.04%	145
2018 Q1	$679K	Buy	6,095 +100	+2%	+$12K	0.11%	80
2017 Q4	$717K	Sell	5,995 -735	-11%	-$89.5K	0.1%	91
2017 Q3	$944K	Sell	6,730 -3,465	-34%	-$471K	0.14%	108
2017 Q2	$1.24M	Sell	10,195 -1,978	-16%	-$230K	0.17%	78
2017 Q1	$1.48M	Buy	+12,173	New	+$1.57M	0.21%	71

Other funds holding ALXN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Bank Pictet & Cie (Europe)'s ALXN Position: Q4 2020 in Review

Bank Pictet & Cie (Europe) sold out of Alexion Pharmaceuticals (ALXN) in Q4 2020, closing a stake of 34,060 shares — an estimated $3.9M sold.

Bank Pictet & Cie (Europe) first reported a position in ALXN in Q1 2017 and held it in 9 quarters. The position peaked at $3.9M in Q3 2020. 825 funds tracked by Wall St. Rank hold ALXN as of Q4 2020.

Bank Pictet & Cie (Europe) reported no remaining Alexion Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
Bank Pictet & Cie (Europe) sold 34,060 Alexion Pharmaceuticals shares in Q4 2020, an estimated $3.9M.
Bank Pictet & Cie (Europe) first reported a position in Alexion Pharmaceuticals in Q1 2017 and held it in 9 quarters.
Bank Pictet & Cie (Europe)'s Alexion Pharmaceuticals position peaked at $3.9M in Q3 2020.
825 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q4 2020.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q4 2020, filed 11 Feb 2021.